Tag: Prescription Drugs
Ide-Cel Beneficial in Relapsed, Refractory Multiple Myeloma
Ide-cel significantly improves progression-free survival and response compared with standard regimens
Long-Acting Injectable Preferred for HIV Preexposure Prophylaxis
Few side effects and low cost were the two most important decision-making factors
Pegylated Interferon Lambda Effective in Preventing Severe COVID-19
Incidence of hospitalization or emergency department visit lower for those receiving interferon versus placebo
Difelikefalin Improves Itch Intensity in Notalgia Paresthetica
However, more frequent headache, dizziness, constipation, increased urine output seen for patients receiving difelikefalin versus placebo
ASA: Sex Differences Seen in Use of Dual Antiplatelet Therapy After Minor Stroke
Overall, dual antiplatelet therapy was prescribed to only 40 percent of discharged patients
Could a Vibrating Pill Ease Chronic Constipation?
Recently FDA-approved pill, Vibrant, stimulates the colon, causing muscle contractions that move food out
Momelotinib Yields Clinically Significant Improvement in Myelofibrosis
Significantly greater proportion of patients reported 50 percent or greater reduction in total symptom score with momelotinib versus danazol
Inflation Reduction Act Estimated to Yield Billions in Drug Savings
Ceiling prices for negotiation would have reduced Medicare prescription drug spending by ~5 percent if implemented from 2018 to 2020
Alternative to Lenalidomide ID’d for Maintenance in Multiple Myeloma
Maintenance therapy with carfilzomib, lenalidomide, and dexamethasone may be superior for multiple myeloma after autologous stem cell transplantation
Persistent Gaps Exist in Continuity of Medication Use for Adults With Diabetes
Mean of 19.5, 17.1, and 43.3 percent of participants did not maintain continuity of use of glucose, BP, lipid medications
